INVESTMENT IN EARLY-STAGE RESEARCH WILL PAY OFF IN MORE ISRAELI BIOTECH (HEBREW)
27 October 2009
Following the debate on the allocation of public funding to the new Biotech Fund, Yissum CEO Yaacov Michlin explains the advantage of investing in biotechnology research